Daniel R. Chard - Dec 31, 2021 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Dec 31, 2021
Transactions value $
-$2,415,356
Form type
4
Date filed
1/4/2022, 03:05 PM
Previous filing
Nov 23, 2021
Next filing
Apr 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Options Exercise +24.1K +153.17% 39.8K Dec 31, 2021 Direct F1
transaction MED Common Stock Tax liability -$2.42M -11.5K -28.99% $209.43 28.3K Dec 31, 2021 Direct
transaction MED Common Stock Gift $0 -12.5K -44.38% $0.00 15.7K Jan 3, 2022 Direct F2
transaction MED Common Stock Gift $0 +12.5K +13.84% $0.00 103K Jan 3, 2022 The Dan and Allyson Family Irrevocable Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 12,036 Performance Stock Units were granted on February 20, 2019, and vested on December 31, 2021 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors.
F2 The reporting person transferred these shares to The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
F3 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.